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simultaneously in isolated tissue samples, up until now, 
these methods were not suitable to analyze lipids in the 
airway epithelium. To determine all major lipid classes in 
airway epithelial cells, we used an LC–MS-based approach 
that can easily be combined with the specific isolation pro-
cedure to obtain epithelial cells. We tested the suitability of 
this method with a mouse model of experimental asthma. 
In response to allergen challenge, perturbations in the 
sphingolipids were detected, which led to increased lev-
els of ceramides. We expanded the scope of this approach 
analysing human bronchus samples without pathological 
findings of adenocarcinoma patients. For the human lung 
epithelium an unusual lipid class distribution was found in 
which ceramide was the predominant sphingolipid. In sum-
mary, we show that disease progression and lipid metabo-
lism perturbation can be monitored in animal models and 
that the method can be used for the analysis of clinical 
samples.
Abstract Airway epithelial cells play an important role 
in the pathogenesis of inflammatory lung diseases such as 
asthma, cystic fibrosis and COPD. Studies concerning the 
function of the lipid metabolism of the airway epithelium 
are so far based only on the detection of lipids by immu-
nohistochemistry but quantitative analyses have not been 
performed. Although recent advances in mass spectrom-
etry have allowed to identify a variety of lipid classes 
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Lipid species are abbreviated as follows: [abbreviation 
of the lipid class] [sum of carbon atoms in all fatty acid 
residues]:[number of double bonds], e.g. PC 36:1 describes 
phosphatidylcholine containing 36 carbon atoms and one double 
bond in the fatty acid chains.
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The role of lipids in pulmonary inflammatory diseases has 
gained increasing interest in recent years [1–6]. Previously, 
solely seen as essential components of membranes and 
energy sources, lipids are now regarded as important com-
ponents of the immune response either by organizing sign-
aling complexes in membranes such as lipid rafts [7] or by 
influencing the immune reaction by release of lipid-derived 
mediators such as arachidonic acid derived mediators [8] or 
sphingosine-1-phosphate [9].
Recent results indicate that changes in the lipid con-
tent of the airway epithelium play an important role in 
chronic airway diseases such as cystic fibrosis, COPD, and 
asthma. In cystic fibrosis, an increase in ceramide amounts 
was detected in the airway epithelium and was linked to 
inflammation, cell death and infection susceptibility [4]. 
Recent studies indicate that epithelial lipid metabolism is 
also changed in asthma [6, 10, 11]. For example, increased 
amounts of ceramides were detected in the airway epithe-
lium of a guinea pig model as response to the induction of 
experimental allergic asthma [12]. Further support for an 
important role of lipid metabolism was found by genome 
wide association studies that identified the Orosomuid 
1 like 3 (ORMDL3) gene to be strongly associated with 
childhood asthma [13]. ORMDL genes, which regulate 
ORM protein expression, are expressed in airway epithe-
lial cells [14] and their expression is strongly increased 
in response to allergen challenge [15]. Functional studies 
have shown that the ORM families of proteins are regula-
tors of the sphingolipid biosynthesis [16] pointing towards 
an important role of sphingolipids in the sensitization 
phase of asthma. Studies that identified the airway epi-
thelium as cellular source of sphingolipids relied only on 
immunohistochemistry. Although immunohistochemistry 
is able to detect the cellular source of single lipids, only 
very limited information can be gathered regarding the 
amount of lipids as well as the lipid composition in these 
cells [12]. However, this information is crucial to under-
stand the molecular mechanisms that underlie changes in 
lipid composition and possible cellular consequences of 
therapeutic interventions.
Recent advances in mass spectrometry have allowed 
identifying and quantifying a variety of lipid classes simul-
taneously. In the shotgun lipidomics approach lipid extracts 
are analyzed in direct infusion experiments solely relying 
on the performance of the tandem mass spectrometer uti-
lized (MS/MS) [17–19]. This approach is fast and reliable 
for profiling lipidomes of a variety sample types [20–22]. 
However, lipid extracts containing considerable amounts of 
impurities, cannot be analyzed by shotgun lipidomics due 
to ion suppression effects. In such cases, liquid chroma-
tography–mass spectrometry (LC–MS)-based methods are 
chosen [23–26]. The LC-separation as second analytical 
dimension is a must for the quantitation of very low abun-
dant molecular species and lipid-derived signal molecules 
[27–29].
Here, we present a new lipidomics approach to deter-
mine the lipid content of airway epithelial cells, which 
was extensively tested in a mouse model of experimen-
tal asthma and applied to clinical samples. This method 
has previously been used to determine epithelial mediator 
mRNA expression [30] and was now optimized for lipid 
analysis using LC–MS. Epithelial cells were isolated with 
a sterile swab and was processed for the analysis by either 
normal phase (NP) or reversed phase (RP) LC–MS using 




All lipid standards with purities greater than 99 % were 
obtained from Avanti Polar Lipids (Alabaster, AL, USA). 
Deionized water was prepared with a Milli-Q purifica-
tion system (Schwalbach, Germany); the conductivity of 
the water was less than 0.06 µS cm−1. All other chemi-
cals (at least HPLC grade) were obtained from Sigma 
Aldrich (Traufkirchen, Germany) and used without further 
purification.
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Animal Model of Allergic Airway Inflammation
Female Balb/c mice aged 8 weeks were treated intranasally 
with a crude extract of house dust mite (HDM) (Greer, 
Lenoir, NC, USA) in PBS (100 µg/50 µL) (n = 6) or PBS 
alone (n = 6) on days 0, 7, and 14. On day 15, the tracheae 
were removed and the epithelium was isolated as described 
below. Experiments were performed in two independent 
batches. All animals were held according to institutional 
guidelines with a 12 h day/night cycle and food and drink 
ad libitum. All animal experiments were approved by the 
Regierungspräsidium Giessen (Landgraf-Philipp-Platz 1-7, 
35390 Gießen, Germany) and measures were taken to keep 
animal suffering to a minimum.
Isolation of Murine Tracheal Epithelium
To isolate the tracheal epithelium, the mice were killed 
by an overdose of isoflurane. The trachea was removed, 
transferred to a small cork plate with the tracheal mus-
cle facing upwards and were fixed in position with insect 
needles. Hepes-Ringer solution was constantly applied 
to prevent drying of the tissue. Then, the tracheal muscle 
was cut using Vannas-Tübingen spring scissors and the 
tissue was flattened using additional insect needles. The 
epithelial surface was cleaned by rinsing repeatedly with 
HEPES-Ringer solution. Excess fluid was drained using 
a pipette without touching the epithelium. The epithelium 
was gently removed using a sterile swab (Single Polyester 
Fiber-Tipped Applicator Swab, Becton–Dickinson, Heidel-
berg Germany). The tip of the swab was cut with a sterile 
scalpel, transferred to a 1.5 mL Safe-Lock Eppendorf tube 
(Eppendorf AG, Hamburg, Germany), shock-frozen in liq-
uid nitrogen and stored at −20 °C until the analysis.
Electron Microscopy
After removal of the murine epithelium, the trachea on the 
cork plate was transferred to a vial containing 2 % (v/v) 
glutardialdehyde, 0.6 % (w/v) paraformaldehyde, and 
0.03 % (w/v) CaCl2 in 0.06 M cacodylate buffer, pH 7.3521 
and fixed for at least 24 h. Then, the tissue was rinsed with 
cacodylate buffer, dehydrated in increasing concentrations 
of acetone, critical point dried, sputtered with gold and 
evaluated using a scanning electron microscope. Using 
ImageJ the total amount of epithelium removed from each 
trachea was calculated in 10 tracheae.
To further evaluate the procedure, tracheae from 
mice which were not treated intranasally were treated as 
described above but were processed for transmission elec-
tron microscopy after fixation. First, they were additionally 
fixed with osmium tetroxide, dehydrated with increasing 
concentrations of alcohol, transferred to propylene oxide 
and embedded in Araldite resin. Ultrathin sections were 
cut, transferred to grids, stained with lead citrate and uranyl 
acetate and evaluated by transmission electron microscopy.
Lipid Extraction of Murine Tracheal Epithelial Cells 
on Sterile Swabs
Mice tracheal epithelial cells on swabs were extracted 
according to Bligh and Dyer [31]. Briefly, 40 µL water 
were added to the swab and mixed with 100 µL of metha-
nol and 50 µL of chloroform (sample/methanol/chloro-
form = 0.8/2/1 by volume). The mixture was vortexed and 
sonicated for 10 min. After 25 min at room temperature, 
50 µL of water (1 volume) and 50 µL of chloroform (1 vol-
ume) were added, vortexed and centrifuged for 10 min at 
400×g. The lower organic phase was transferred to another 
vial and the water phase was re-extracted two more times 
with 50 µL of chloroform (1 volume). Organic phases were 
pooled, solvent was removed in vacuum and samples were 
stored at −20 °C. Prior to analysis, dried samples were dis-
solved in 100 µL of chloroform/methanol = 86/13 (v/v) and 
25 µL of the reconstituted sample was mixed with 25 µL 
of a mixture of deuterated lipid standards (1.43 ng µL−1 
per species, consisting of 16:0 D31-18:1 PI, 16:0 D31 Cer, 
16:0 D31-18:1 PG, 16:0 D31-18:1 PE, 16:0 PC D62, 16:0 
D31-18:1 PS, 16:0 D31 SM).
Isolation of Human Bronchus Tissue Samples 
and Epithelial Cells
Human bronchial samples without pathological findings 
were obtained from lung lobes that were removed during 
surgery from one female and two male adenocarcinoma 
patients (age: 61–77 years). Pieces of the main bronchi 
were removed, cut open, fixed with needles on a cork plate 
and remaining mucus was removed. As described above for 
mouse tracheal epithelium, bronchial epithelial cells were 
removed with a sterile swab. In addition, whole bronchial 
tissue samples were also obtained. For each patient at least 
five epithelium samples were processed. After isolation, 
samples were extracted as described below. The use of 
patient materials was approved by the ethics committee of 
the University of Lübeck (AZ 12-220).
Lipid Extraction of Human Bronchus Tissue 
and Epithelium Samples
Prior to lipid extraction, human lung epithelial cells on 
swabs were moistened with 100 µL of water and human 
bronchus tissue samples were homogenized in a 20-fold 
excess of 50 mM KCl. From this tissue homogenate 50 µL 
were processed for lipid extraction, which corresponds to 
approximately, 2.5 mg of tissue sample. After the addition 
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of 50 µL of the internal standard mixture (5 ng/µL per spe-
cies, consisting of 16:0 D31-18:1 PI, 16:0 D31 Cer, 16:0 
D31-18:1 PG, 16:0 D31-18:1 PE, 18:0-18:0 PC-OO, 16:0 
D31-18:1 PS, 16:0 and D31 SM), lipids were extracted 
from the samples according to Bligh and Dyer [31]. Dried 
samples obtained after extraction were stored at −20 °C 
until LC–MS analysis. Prior to NP-LC–MS analysis, the 
residue was re-dissolved in 200 µL of chloroform/metha-
nol = 86/13 (v/v). For RP-MS analysis, 50 µL of this solu-
tion were dried in vacuum and the dried residue was re-dis-
solved in 50 µL of methanol containing 0.1 % ammonium 
acetate.
Normal Phase Liquid Chromatography (NP-LC–MS)
An Agilent 1100 HPLC system (Agilent, Waldbronn, Ger-
many) was used for the separation of the phospholipids on 
a 150 mm BETASIL Diol-100 column with a particle size 
of 5 µm (Thermo Fisher, Bremen, Germany) and 0.32 mm 
inner diameter using 5 μL injection volumes. The solvents, 
gradient profile and flow rates are summarized in supple-
mentary Table 1.
Reversed Phase Liquid Chromatography (RP-LC–MS)
For the analysis of neutral lipids in the clinical samples, the 
Agilent 1100 HPLC system was used for the separation of 
the lipids by reversed phase HPLC on a 150 mm Biobasic 
C18 column (Thermo Fisher) with a 0.32 mm inner diam-
eter using 5 μL injection volumes. The solvents, gradient 
profile and flow rates are summarized in supplementary 
Table 2.
Mass Spectrometry
All mass spectrometric analyses were performed on a 
high resolution Bruker Apex Qe FT-MS (Bruker Dalton-
ics, Bremen, Germany) equipped with a 7 Tesla actively 
shielded magnet and an Apollo Dual ESI/MALDI ion 
source. For TAG analysis, full scan MS data were acquired 
in the first 40 min of the LC acquisition in the positive ion 
mode. For the phospholipid analysis, full scan MS data 
were acquired in the first 60 min of the LC-run. Instru-
mental parameters were as follows: source temperature at 
200 °C, −3.8 and 4.5 kV ionization voltages for negative 
and positive ion mode analysis, respectively. For human 
lung samples 1 M data points sampling rate and 1 s accu-
mulation time for each scan was used and the nebulizer gas 
was set to 1.0 L min−1, drying gas was set to 5 L min−1, 
and TOF time parameter was set to 0.0014. For mouse 
epithelium samples 512 k data points sampling rate and 
0.6 s accumulation time for each scan was used, where 
2 microscans were averaged; nebulizer gas was set to 
1.3 L min−1, drying gas was set to 3 L min−1, and TOF 
time parameter was set to 0.0021. Data acquisition was per-
formed using the HyStar 3.2 software (Bruker Daltonics).
Data Processing
NP-LC–MS and RP-LC- MS data files were processed 
using Bruker’s Data Analysis 4.0 software. Mass spectra 
were averaged in the retention time ranges of lipid classes 
of interest (defined by the elution time of the internal stand-
ards). Each mass spectrum was smoothed, baseline sub-
tracted and finally peaks lists were extracted (m/z values 
and corresponding intensities). Lipids were identified by 
their monoisotopic masses with an accuracy better 5 ppm 
using LipidXplorer [32] and their respective retention time 
window. If available, intensity ratios of lipid species and 
their corresponding deuterated internal standard were used 
for quantification of lipids in the sample. DAG and TAG 
were quantified using 36:0 PC-OO as standard, which 
eluted closest to the elution time range of both lipid classes 
in the RP-LC–MS.
Data Analysis and Statistical Analysis
Statistical tests were performed using GraphPad Prism ver-
sion 6.00 for Windows, (GraphPad Software, San Diego, 
CA, USA). A significant difference between lipid spe-
cies in the two data sets was assumed if p < 0.05 for the 
Mann–Whitney U test.
Results
Selective Removal of Epithelial Cells from Murine Trachea 
Using a Sterile Swab
After trachea removal and rinsing the surface, the epithe-
lial cells were obtained by gently skimming the epithelium 
using a sterile swab. To verify selective removal of epithe-
lial cells from trachea samples, scanning electron micros-
copy and transmission electron microscopy experiments 
were performed. These experiments verified that the swab 
removed the epithelium without destroying the subepithe-
lial dense fiber network and without reaching deeper parts 
of the tracheal tissue (Fig. 1). No remaining mucus or other 
material was detected on the remaining epithelial cells. As 
judged by the area of missing epithelium in the trachea we 
estimated that in average 5.23 ± 0.12 mm2 (n = 10) was 
removed using the swab. Such area would correspondent to 
approximately 80,000 cells, which subsequently were pro-
cessed for lipid extraction and LC–MS analysis.
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Analysis of Epithelial Lipids Using NP-LC–MS
Initially, we intended to analyse swab lipid extracts in a 
shotgun lipidomics approach allowing high-throughput 
sample analysis. Unfortunately, analyses without pre-sep-
aration were not successful due to contaminants from the 
swab plastic material, which gave rise to two major peaks 
at m/z 594.1605 and m/z 1170.2883 in the positive ion 
mode. These contaminants made a sensitive lipid quan-
titation impossible due to strong ionization suppression. 
Note, several other swabs made from different material 
were tested but showed even higher chemical background. 
To overcome these issues and to allow automated data 
analysis using LipidXplorer, an NP-LC–MS method was 
implemented.
The sensitivity and reproducibility of the NP-LC–MS 
method for phospholipid analysis was estimated using a 
lipid standard mixture containing Cer, PG, PE, PI, PS, SM, 
and PC. The limit of detection (LOD) for all lipids was in 
the range of some hundred fmol on column (supplemen-
tary Table 3). For PS the LOD was in the low pmol range 
as this lipid class elutes very late under the chosen chro-
matographic conditions resulting in peak broadening and 
reduced signal intensity in the resulting mass spectra.
To identify and quantify lipids using NP-LC–MS anal-
ysis, all mass spectra in the elution time range of a spe-
cific lipid class of interest were averaged. Thus, retention 
time stability is of crucial importance for automated data 
analysis. Retention time stability was determined from 25 
subsequent analyses for the three standard lipids eluting at 
different retention times (16:0 D31 Cer at 1.2 min, D31-
18:1 PE at 14 min, 16:0 D31-18:1 PS at 32 min) and found 
to have only relative standard deviation of 5 %. It should 
be noted that retention time ranges used for quantification 
of phospholipids were adjusted for each batch of samples 
analysed as retention time discrepancies were observed 
between different column batches and mobile phase prepa-
rations. In our study, sets of up to 30 epithelium samples 
were measured and mass spectra for specific lipid classes 
could automatically be processed because the retention 
times within one batch remained stable despite matrix 
effects (see supplementary Fig. 1). The established work-
flow for the analysis of lipids from airway epithelial cells 
is summarized in Fig. 2a. Epithelial cells are removed from 
the trachea using a sterile swab and lipids are extracted 
using standard extraction procedures. Extracts are ana-
lysed using NP-LC to separate chemical contaminants of 
the swabs from the lipids. High resolution ESI-FT-ICR-
MS spectra were acquired online and within defined reten-
tion time windows for each lipid class one mass spectrum 
was obtained (Fig. 2b). Peak lists were computed with 
standard spectra processing tools, which were used as 
input for lipid identification using the LipidXplorer soft-
ware. Lipid quantitation was achieved using the response 
of an internal standard that co-eluted with the lipid class 
of interest.
Fig. 1  Electron microscopy of 
murine tracheae after epithelial 
removal. a, b Scanning electron 
micrograph of a murine trachea 
after removal of the epithelium 
with a sterile swab. a View of 
the whole trachea, arrows indi-
cate holes from insect needles. 
b Magnification of the boxed 
area in a. The arrowheads 
indicate the border between 
removed epithelium (r) and 
remaining tracheal epithelium 
(e). c, d Transmission electron 
microscopy of an area with 
preserved (c) and removed 
(d) epithelium. Red arrows 
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Sensitive Analysis of Ceramide Molecular Species in the 
Negative Ion Mode
For the analysis of lipids extracted from murine tra-
cheal epithelial cells, a chloroform-based solvent system 
was used for separation of lipids on a normal phase col-
umn [25]. Use of this solvent system favors formation of 
[M + Cl]− ions of ceramides while the [M-H]− ions are 
barely detectable in the negative ion mode as is shown in 
supplementary Fig. 2a. In the positive ion mode, [M + H]+ 
a
b
Fig. 2  a Workflow for the analysis of lipids in murine and 
human lung epithelial cells. Epithelial cells are removed from tra-
chea samples using a sterile swab. The tip of the swab is subse-
quently extracted using chloroform/methanol and measured using 
NP-µHPLC-ESI FTICRMS in the positive and negative ion mode. 
Mass spectra are averaged in the retention time ranges of lipid classes 
of interest (defined by the elution time of the internal standards), 
smoothed, baseline subtracted and peaks lists (m/z values and cor-
responding intensities) are exported for each mass spectrum. Lipids 
in the mass spectra were identified by their monoisotopic masses 
(5 ppm accuracy) and their retention time using LipidXplorer. b 
Typical LC-MS base peak ion chromatogram obtained from epithe-
lium cells (upper left) and exemplified mass spectra obtained after 
averaging mass ranges used for identification of PI (upper right), PS 
(lower left), and PG (lower right). (Asterisk unknown compound not 
observed in blank controls)
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ions of ceramides are formed (supplementary Fig. 2b) but 
with comparably low ionization efficiency. (supplementary 
Fig. 2a, b). In addition, swab contaminants co-eluted with 
ceramides and were detected at high abundance in the posi-
tive ion mode. As a result of these observations, we choose 
to quantify ceramide species as chloride adducts in the neg-
ative ion mode, which was also reported earlier [33–35].
Lipid Composition of Murine Tracheal Epithelial Cells 
and Changes due to Induction of Experimental Asthma
In the present work, we analysed lipids in epithelial cells 
obtained directly from murine trachea. From approxi-
mately, 80000 cells collected, 99 lipid species belonging to 
seven different lipid classes were identified and quantified 
in pmol/sample. SM and PC were found to be the major 
components of epithelial cells of the mouse trachea with 
approximately 68 molpercent (PC and PC-O: 41 %, SM: 
26 %) followed by PE and PE-O (19 %). As minor compo-
nents of the membrane lipids, PI (6 %), PS (4 %), PG (1 %) 
and Cer (1 %) were identified (supplementary Table 4).
Sphingolipid metabolic perturbations were recently 
implicated as important risk factors for childhood asthma 
[36]. In this regard, we tested if our method could help to 
assess lipid metabolic changes in the epithelia between 
house dust mite challenged mice (HDM) and control ani-
mals (PBS) (Fig. 3). Here we could observe that cera-
mides were predominately changed on the lipid class 
level after HDM challenge. A closer look into the cera-
mide profile revealed that all species after HDM challenge 
were increased (Fig. 3 inset). Further prominent changes 
were found for PC-O 32:0, PC-O 34:1 and PS 34:1 that 
are significantly increased in HDM challenged animals, 
whereas PG 34:2 and PG 32:1 are significantly decreased 
when compared to control mice (supplementary Table 4, 
p < 0.05, Mann–Whitney test).
The Lipidome of Human Bronchus Epithelial Cells
Encouraged by the results of the mouse model we tested 
whether our method could in principle also be applied for 
the human bronchial epithelium. Subsequently, epithelium 
cell samples were obtained from different locations of 
explanted bronchial tissues of confirmed adenocarcinoma 
patients that did not show histological alterations in the 
excised bronchi. The abundance of selected lipid classes 
in the bronchus epithelial cells obtained from three dif-
ferent patients is shown in Fig. 4. For the analysis of the 
human airway epithelial cells approximately, a tenfold 
higher amount of biological material can be obtained as 
compared to the murine trachea. That further resulted in 
an increase of lipid identifications to approximately, 300 
lipids (supplementary Table 5). For all patients, epithelium 
samples were isolated on at least five locations of the bron-
chus. It further enabled us to determine the variability of 
lipid profiles for the three individuals. For all patients, PC 
was found to be the most abundant lipid class followed by 
PE plus PE-O. For patient 2 a high variability compared 
to the other patients was detected in the lipid content of 
TAG, SM and Cer, which cannot be attributed to a specific 
functional or clinical parameter. In future studies, the num-
ber of patients has to be increased to access the inter- and 
intra-individual lipidome variability to draw functional 
associations. We further tested the specificity of the isola-
tion technique by comparing whole bronchial tissue sam-
ples with isolated epithelium samples (Table 1). On level 
of the lipid class distribution the strongest difference can be 
found in reduced TAG amounts in the epithelium, which is 
related to peribronchial adipose tissue. We further observed 
a clear increase in abundance for Cer, PE-O and PE lev-
els in the epithelium (Table 1). A closer look into the Cer 
and SM profiles revealed a shift towards shorter acyl chains 
for the epithelium samples (Fig. 5 a, b). This effect is more 
prominent for the ceramides where Cer 34:1 abundance is 
increased by a factor of 2 compared to the whole bronchus. 
It is further an important observation that Cer is the pre-
dominant sphingolipid in the epithelium, which was not 
expected.
Lipid Profiles of Mouse and Human Airway Epithelium
For many respiratory diseases are mouse models estab-
lished, which help to investigate fundamental processes 
in disease progression [37–40]. Here we present the first 
Fig. 3  Lipid class distribution in pmoles/sample determined in 
murine tracheal epithelial cells of animals challenged using house 
dust mite extract (red) and healthy controls (blue). The inset shows 
the single species distribution of ceramide species normalized to con-
trol samples (PBS). Bar graphs (main panel) and scatter dot plots 
(inset) show mean ± SD. Significantly changed species (Mann–
Whitney U test) are marked with asterisks: *p < 0.05; **p < 0.01; 
***p < 0.001
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comparison of the lipid composition of mouse and human 
airway epithelium. PC was in both epithelia the most abun-
dant membrane lipid (Fig. 6a). A striking difference was 
observed in the abundance of SM, which in the mice is 
as nearly abundant as PC. For the human epithelium we 
observed that Cer is the most abundant sphingolipid and 
approximately, tenfold more abundant compared to the 
mouse. Further changes were found for the PC-O content, 
which was significantly decreased in the human airway 
epithelium whereas for PG a slight increase of 25 % was 
observed. In context of the importance of sphingolipids we 
like to underline that the acyl chain distribution in cera-
mides as well as sphingomyelin is very different (Fig. 6b, 
c) between mouse and human airway epithelium. For the 
human as well mouse airway epithelium the Cer 34:1 
and SM 34:1 are the predominant species. But long chain 
sphingolipids make up a higher proportion in the mouse 
epithelium, which can be best recognized for Cer 40:1, Cer 
42:1 and SM 42:2. The functional impact of such global 
lipid changes is until now out of our reach, but might be of 
importance in the future when results of animal models are 
translated for clinical application.
Fig. 4  Lipid class distribution for selected lipid classes in of human 
airway epithelial cells obtained from three different patients. N = 3 
patients, at least five samples per patient were analyzed, each dot cor-
responds to one swab containing epithelial cells, which was extracted 
and analyzed using the workflow shown in Fig. 2
Table 1  Lipid class distribution 
in epithelial cells and bronchus 
tissue samples obtained from 
three different patients
Bold values indicate lipid 
significantly increased in lung 
epithelial cells when compared 
to lung tissue samples and 
italic values indicate significant 
decrease in lung epithelial cells 
when compared to lung tissue 
samples
Values are expressed as mol % 
of total identified lipid species
SD standard deviation, N 
number of swabs/tissue samples 
analyzed
Bronchial tissue samples Bronchial epithelial cells Mann–Whitney U test
Mean SD N Mean SD N p value
Cer 12.89 2.99 17 2.98 1.49 10 <0.0001
PE-O 10.48 2.78 17 4.74 2.93 10 <0.0001
PE 8.48 2.18 17 2.72 1.93 10 <0.0001
PG 1.60 0.56 17 2.62 0.73 10 0.0007
PI 6.66 2.29 17 2.83 2.05 10 0.0003
PS 4.58 1.36 17 5.62 1.43 10 0.0742
PC-O 1.14 0.18 17 1.77 0.33 10 <0.0001
PC 36.52 8.64 17 30.26 7.30 10 0.0511
SM 3.13 0.80 17 6.14 1.04 10 <0.0001
DAG 0.09 0.10 17 0.40 0.18 10 0.003
TAG 14.48 15.60 17 39.93 13.55 10 0.0004
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Discussion
A method was developed to investigate the lipid composi-
tion of lung epithelia using a sterile swab for cell isolation 
and LC–MS for quantitation. The approach was tested in 
a mouse model of experimental asthma and human sam-
ples. Even though standard plastic consumable were uti-
lized for the isolation of the epithelia this method allowed 
Fig. 5  Sphingolipid profiles of human bronchus. a Ceramide (Cer) 
and b sphingomyelin (SM) single species distribution (mol % of 
total identified Cer and SM, respectively) of human bronchial epi-
thelial cells and bronchus tissue samples. Epithelium samples: n = 3 
patients, at least five samples per patient were analyzed; bronchus 
tissue samples: n = 3 patients, at least two samples per patient were 
analyzed. Bar graphs show mean ± SD
Fig. 6  Lipid profiles of murine and human airway epithelial cells. 
a Membrane lipid class distribution, b single species distribution of 
even-numbered ceramide species identified, c single species distribu-
tion of even-numbered sphingomyelin species identified. Bar graphs 
show mean ± SD; significantly changed species (Mann–Whitney U 
test) are labeled with asterisks: *p < 0.05; ****p < 0.0001
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quantifying many important membrane lipids. In this way, 
a molecular snapshot of the lipid metabolism of the airway 
epithelium can be derived, which will help to investigate 
the influence of the lipid metabolism on lung diseases. To 
our knowledge, we report for the first time the lipid profiles 
of phospholipids, sphingolipids and neutral lipids of airway 
epithelial cells.
Our method is sensitive enough to quantify ceramide 
species in the airway epithelium. In general, ceramides 
and sphingolipids are implicated as key molecules in the 
development of asthma and inflammatory processes [6, 
11, 36]. Our observation of increased ceramide amounts 
in allergen-challenged mice supports this finding. This 
view is also supported by a recent study in which inhibi-
tion of Cer synthase resulted in a decrease of Cer levels in 
lung tissue samples in a guinea pig model of experimen-
tal asthma and reduced asthmatic hallmarks in challenged 
animals [12].
For the analysis of intrapulmonary airway epithelium of 
mice, however, our technique will be of limited use due to 
the large size of the sterile swab. To improve the depth of 
lipidomics studies, other techniques to isolate the epithe-
lium have to be found. The use of laser capture microdis-
section can be a promising approach to study lung tissue 
sections [41] as well as MALDI-based mass spectrometric 
imaging [42]. To further enhance the impact of such stud-
ies we will expand our approach to LC–MSn-based tech-
niques that enable us to measure secondary messenger like 
lipid mediators, sphingosines and lyso-lipids [43]. We have 
shown that this method is also applicable to specifically 
analyze the lipid composition of human epithelial samples 
obtained from explanted lung samples. Since epithelial 
brushings can be performed by bronchoscopy, our method 
could be a useful tool to study the lipid metabolism of the 
human airway epithelium of patients.
Conclusions
We developed a LC–MS-based method that can become a 
valuable tool to investigate the role of lipids in the airway 
epithelium in context of respiratory diseases. The approach 
is applicable for mouse model as well as to profile lipids 
of the human airway epithelium. Our method can in prin-
ciple be used to analyze lipid profiles of epithelium cells 
obtained by epithelial brushings performed during bron-
choscopy. We see here the possibility to utilize this plat-
form technology for clinical application.
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